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ABSTRACT. Apathy and depression are the most
prevalent neuropsychiatric symptoms in Alzheimer’s
disease and mild cognitive impairment. Despite much
research on apathy and depression in dementia, the
nosological position of apathy as a separate syndrome
from depression remains debated. This literature review
provides a critical analysis of the areas of clinical
manifestation, symptomatology, assessment, preva-
lence and neuropathology. Evidence does not pro-
vide a clear view of the nosological position of apathy
in dementia for symptoms and neuropathology. How-
ever, the ambiguity of the evidence may be attributed
in large part to a lack of clarity in definition and eti-
ology, clinical criteria and assessment overlap. Given
the evidence, it is concluded that the argument in fa-
vor of apathy as a separate syndrome from depression
in dementia is persuasive. Reaching a consensus on the
definition and nosological position of apathy within de-
mentia is vital to provide patients and caregivers with
the support they require, increase understanding of risk
factors, and enable comparisons across research and
practice.
(Aging Clin Exp Res 2012; 24: 305-316)
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a separate syndrome from depression remains debated
(3, 8, 9) despite extensive research. Review and re-
search papers mostly address this issue only briefly,
not providing in-depth understanding of how and why
apathy and depression differ in dementia. For example,
Ishii et al. (7) provided a detailed review on apathy as a
common psychiatric syndrome in the elderly, but offered
only a subsection on the differentiation analysis, both in
support of apathy as a separate syndrome from de-
pression and apathy as a symptom of depression. To our
knowledge, only Tagariello et al. (9) provide a literature
review on this specific subject. Due to its brevity, it
only provides a summary of the main issues and does
not provide a comprehensive evaluation. The present
paper provides an in-depth analysis, examining re-
search both in support of apathy as a separate syndrome
from depression and apathy as a symptom of depres-
sion.
APATHY IN DEMENTIA
Apathy is a behavioral and personality change promi-
nently observed in AD, and is generally defined as a loss
of motivation, manifested in behaviors of diminished
initiation, poor persistence, lack of interest, indiffer-
ence, low social engagement, blunted emotional re-
sponse, and lack of insight, not attributable to decreased
consciousness levels, cognitive impairment or emotion-
al distress (10, 11). Marin et al. (12-14) originally defined
apathy as a lack of motivation (i.e., direction, intensity
and persistence of goal-directed behavior) relative to
the patient’s previous level of functioning or standards of
age and culture, as indicated either by subjective ac-
counts or observations by others. While their (13, 14)
concept of apathy centers on reduced goal-directed be-
havior, cognition or emotion (15), modern conceptual-
izations acknowledge apathy as reflecting a multitude of
INTRODUCTION
Apathy and depression are prevalent neuropsychiatric
symptoms in Alzheimer’s disease (AD) and mild cogni-
tive impairment (MCI) (1). While closely clinically relat-
ed, demonstrating co-morbidities and key symptom
overlap (e.g., loss of interest and motivation, reduced ac-
tivity or hedonism, and lack of insight) (2, 3), they are al-
so pathophysiologically distinct (4), and several studies
indicate two separate syndromes, with differential preva-
lence rates, neuropsychiatric symptoms and cognitive
functions (2, 4-7). The nosological position of apathy as
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dimensions (16): a disorder of motivation, with cognitive,
sensory, motor and affective subtypes (12); a disorder of
interest or motivation, including lack of emotion, initia-
tion and enthusiasm (17); a disorder of initiative, mani-
fested in a lack of self-initiated action (affective, behavioral
or cognitive) and including ‘social apathy’ (a disorder of
the sense of self and of social awareness) (18); a disorder
of motivation, with emotional blunting, lack of initiative
and lack of interest (19); a disorder of intellectual curiosity,
action initiation, emotion and self-awareness (20); a dis-
order of voluntary and goal-directed behaviors, with
three subtypes of disrupted “signal” processing: emo-
tional-affective, cognitive and auto-activation (15); and a
disorder of motivation, with diminished goal-directed
behavior and cognition (21). Despite these differing
views on the core features of apathy – namely, whether
the central feature of apathy is disturbance of motivation
(12) or initiative and self-generated voluntary and pur-
poseful behavior (15, 18) – the consensus is that moti-
vation, interest, action, initiation and emotional reactiv-
ity are dimensions of apathy, in which the changes in mo-
tivation may relate to either internal (self-conducted be-
havior) or external stimulation, and that the lack of mo-
tivation is central to the disorder (16). A correlation has
been found between apathy and increased cognitive im-
pairment, as well as lower cognitive test performance (22,
23), higher conversion rates from MCI to AD (24), de-
pression (25, 26), and increased impairment in functional
activities (10, 27). Notably, while Robert et al. (28)
found no association between apathy and executive dys-
function, recent studies demonstrate apathy to be linked
– especially in the early stages of cognitive dysfunction
(i.e., MCI) – with executive dysfunction and especially
worse performance in verbal memory, naming, set shift-
ing and verbal fluency (29-31).
Apathy is an important indicator of early AD diag-
nosis, strongly correlated with more impairments of
daily living activities than normally associated with cog-
nitive status, increased dependency on caregivers to
initiate activities and provide support and management
(e.g. initiation of activities for which the patient is actually
still capable of performing independently), reduced
quality of life, rapid progression of cognitive degenera-
tion and various psychobehavioral disturbances, which
all contribute to heightened caregiver distress and bur-
den (5, 10, 11, 27, 32-36). Assessing apathy in AD is
complicated, as loss of motivation must be differentiat-
ed from loss of ability (11). This is particularly difficult in
the cognitively impaired, as apathy is generally defined
as a reduction in behavior in comparison to the patient’s
pre-morbid state (11). Cognitive function decline com-
plicates such an assessment, as patients face increased
difficulty in the organization and conduct of complex be-
haviors, reduced behavior resulting from impaired mo-
tivational abilities, reduced task initiation, and increased
frustration and confusion with hobbies (11, 13, 37). Al-
though apathy is a behavioral sign of cognitive dys-
function in which impairments negatively affect the ini-
tiation, planning, and problem-solving of successful
task performance (11, 38-40), Marin and Wilkosz (41)
observed apathetic individuals generally to be ‘able to ini-
tiate and sustain behavior, describe their plans, goals and
interests, and react emotionally to significant events
and experiences’ despite diminished motivation associ-
ated with apathy (21, pp. 1088-1089). Apathy must
therefore be distinguished from cognitive decline, as
the dynamic interaction between apathy and cognitive
impairment may result in AD patients demonstrating less
interest in regular activities as they lose the ability to en-
gage in cognitively complex behaviors and become less
likely to initiate regular activities in which they are unsure
of the steps required (11). Consequently, apathetic
symptoms must be considered when increased func-
tional impairments and reliance on caregiver initiation
become more evident than expected for a given level of
cognitive impairment (11).
The need for applicable diagnostic criteria for apathy
in dementia was originally addressed by Starkstein et al.
(10, 21) and recently revised by Robert et al. (16).
Starkstein et al. (10, 21) operationalized the definition
of apathy of Marin et al. (12) into applicable diagnostic
criteria which require: 1) the presence during most of the
day for a minimum of 4 weeks of at least one symptom
of diminished goal-directed behavior (e.g., lack of effort
and initiative, or energy to perform everyday activi-
ties; dependency on prompts from others to structure ev-
eryday activities); diminished goal-directed cognition
(e.g., lack of interest in learning new things or in new ex-
periences; lack of plans and goals, lack of concern
about one’s own health, functional status or personal
problems) or diminished concomitants of goal-directed
behavior (e.g., unchanging or flat affect; lack of emo-
tional responsiveness to positive or negative events
and restricted responses to important life events); 2) clin-
ically significant distress or impairments in social, oc-
cupational or other important areas of functioning
caused by apathetic symptoms; and 3) symptoms are not
due to a diminished level of consciousness or direct
physiological substance effects (e.g., drug abuse, medi-
cation) (10, 21). Thus, diminished motivation, initiative
and interest, and emotional blunting are at the core of
Starkstein et al.’s definition of apathy (16). These criteria
have recently been revised into semi-operationalized
criteria by Robert et al. (16) based on the synthesis of
current concepts of apathy applicable to both research
and practice. The revised criteria follow Starkstein et al.
(10, 21) structure, and require: 1) loss of or dimin-
ished motivation compared with previous functioning lev-
els, not consistent with age or culture, and reported ei-
ther by the patient or observers; 2) the presence of
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impairments (minimum of one symptom) in at least
two of the apathetic dimensions of reduced goal-di-
rected behavior, goal-directed cognitive activity, and
emotions in which motivational changes are assessed by
responsiveness to either internal (self-conducted be-
havior) or external stimulation (16); 3) functional im-
pairments attributable to apathy; and 4) the exclusion of
symptoms and conditions mimicking apathy (42). Future
research is required to assess not only the reliability
and validity of these criteria, but also the proposed dis-
tinction between changes in motivation relating to in-
ternal and external stimulation and the impact which
such differentiation may have.
DEPRESSION IN DEMENTIA
Depression in AD is characteristically expressed by the
high frequency of motivational disturbances (e.g., fa-
tigue, psychomotor slowing and apathy), symptoms of so-
cial isolation, withdrawal, irritability or emotional dis-
tress, and vegetative symptoms of diminished interest, psy-
chomotor retardation, fatigue, hypersomnia and lack of in-
sight (2, 13, 43-46). While these vegetative symptoms are
also key symptoms of apathy (2, 13, 44), depression dif-
fers from apathy according to key clinical dysphoric
symptoms of sadness, feelings of guilt, self-criticism,
helplessness and hopelessness (44), and concurrent reports
in the literature propose dysphoria and loss of interest as
the most common symptoms of depression in AD (46,
47). However, these findings may be tautological, due to
assessment requirements (46, 47). Notably, depressive AD
patients demonstrate significant impairments in quality of
life, activities of daily living and executive function, al-
though no differences are observed for attention, lan-
guage, memory and visuospatial functions compared
with patients with no changes in mood (48-53). Depres-
sion in AD has far-reaching consequences. For AD pa-
tients, depression is associated with increased likelihood
of physical aggression, being discharged from an assisted
living facility and earlier entry into a nursing home, and
higher mortality and suicide; for caregivers, it is associated
with higher personal depression and burden (44, 52,
54-60). Risk factors for depression in AD include a fam-
ily history of mood disorders (affective disorders) in first-
degree relatives, prior personal depressive history, fe-
male gender, and younger age at AD onset (50, 56,
61-65).
Assessing depression in AD is complicated, as symp-
toms of psychomotor slowing, emotional lability, crying
spells, insomnia, weight loss, inability to verbalize affective
states and pessimism are prevalent in both depressed
and non-depressed AD patients (44, 66). Standardized di-
agnostic criteria such as the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM) or the International Clas-
sification of Diseases (ICD) (67) have been implemented
to assess depression in AD. For example, in the DSM-IV
criteria for depression, a principal symptom is loss of in-
terest or pleasure in activities as opposed to depressed
mood itself (68). However, in the demented, such a loss
of interest or pleasure may reflect more a loss of moti-
vation or ability, rather than a change in affect or de-
pression (5). This symptom overlap (e.g., lack of interest,
anxiety, lack of energy, concentration difficulty, agitation
or psychomotor retardation, sleep and eating disorders)
has not only resulted in blurring between AD and de-
pressive symptomology (46, 47, 60, 67, 69), but also re-
sulted in apathetic individuals meeting the diagnostic cri-
teria for major depression even in the absence of dys-
phoric symptoms (5, 70, 71).
A further limitation of the use of non-dementia specif-
ic assessments is their reliance on ability to report subjective
depressive symptoms verbally (e.g., mood changes, loss of
interest, hopelessness), a process commonly impaired in
AD patients (69). Non-dementia specific diagnostic crite-
ria for depression (e.g., DSM, ICD), developed for use in
younger, cognitively unimpaired individuals, lack sensi-
tivity to differentiate accurately between symptoms of
cognitive decline and depression, and have decreased va-
lidity in AD samples (46, 47, 60, 67, 69, 72). This may be
explained by differences in clinical manifestations of late life
mood disturbance compared with younger life, and the de-
nial by the depressed elderly of sad mood, who rather re-
port lack of feeling or emotion and acknowledge a loss of
interest and pleasure in activities (i.e., the depressive elderly
report fewer affective symptoms – known as ‘depression
without sadness’) (46, 47, 60, 67, 69, 72-74).
Pertinently, depression and dementia overlap in the un-
der-reporting of depressive symptoms by dementia suf-
ferers and increased reliance on caregiver and observa-
tional reports (44, 75). Due to aphasia, many dementia
patients lack the ability to express their distress coherently
– a further complication when diagnosing depression in
AD (44). In addition, the tendency of depressive AD pa-
tients to deny the presence of depressed moods and re-
port instead a lack of feeling or emotion, or loss of interest
and pleasure in activities, hampers diagnosis with non-de-
mentia specific assessments of depression in the elderly,
with and without cognitive impairment (44). This, and the
observed difference in depressive symptoms between
the elderly with and without dementia, led Olin et al. (46,
69) to propose depression in AD as an atypical form, in
which motivational symptoms and delusions are experi-
enced more frequently than by non-cognitively impaired
patients (67, 76, 77).
Such difficulties in assessment led Olin et al. (46, 69)
to develop the National Institute of Mental Health Provi-
sional Diagnostic Criteria for Depression of Alzheimer’s
Disease (NIMH-dAD), based on criteria for major de-
pressive episodes (78), but broadened to include those AD
patients who experience ‘clinically significant affective
disturbances but do not meet the standardized diagnostic
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criteria for depression’ (67, p. 590). The NIMH-dAD
diagnostic criteria have been modified to be indepen-
dent of verbal expression (i.e., subjective reporting) and not
confounded by cognitive AD symptomology, and are
aimed at improving understanding of the nosology, eti-
ology and treatment of AD-related depression (46, 69).
The NIMH-dAD criteria require 1) the presence of three
(or more) symptoms of clinically significant depressed
mood (e.g., depressed, sad, hopeless, discouraged, tear-
ful); decreased positive affect or pleasure as a response to
social contact and usual activities; social isolation or with-
drawal; appetite disruption; sleep disruption; psychomo-
tor changes (e.g., agitation, retardation); irritability; fatigue
or loss of energy; feelings of worthlessness, hopelessness,
or excessive or inappropriate guilt; or recurrent thoughts
of death or suicidal ideation (plan or attempt); 2) that all
criteria for Dementia of Alzheimer Type of the DSM-IV-
TR are met; 3) that significant distress or disruption to
functioning is caused by the symptoms; 4) that symptoms
are not exclusive to the course of delirium, nor the direct
result of physiological substance effects (e.g., drug abuse,
medication), or that the symptoms may be better ex-
plained by other conditions (e.g., major depressive dis-
order, bipolar disorder, bereavement, schizophrenia,
schizoaffective disorder, AD psychosis, anxiety disorder,
or substance-related disorder) (69).
The NIMH-dAD proposes that AD-related depression
has heterogeneous etiology characterized as one of four
subtypes: 1) emotional reaction to cognitive deficits in AD
(e.g., adjustment disorder with depressed mood), in which
the depressive state may be a reaction to the diagnosis of
AD and/or associated with the awareness of loss and dis-
ability, or a reaction of certain personality types vulnerable
to depressive symptomology in response to negative life
events; 2) recurrence of early and midlife major and mi-
nor depressive disorders is a risk factor for later life de-
mentia, and may share its etiology with early or midlife de-
pression; 3) vascular diseases associated with AD causing
depressive symptoms (so-called vascular depression), in
which occurrence of subcortical lesions in depressed el-
derly patients with vascular disease indicate that vascular
depression results from ‘critical lesions or an accumulation
of lesions leading to disruption of frontostriatal path-
ways or their modulating systems’; 4) the neurodegener-
ative process of AD causes depressive symptoms (e.g.,
mood disorder due to general medical condition), with
pathophysiological overlap between AD and the depres-
sive syndrome in AD, in which the ‘neurodegenerative
process may directly contribute to the development of de-
pressive symptoms’ (44, pp. 357-358). This set of crite-
ria has been shown to be particularly sensitive, with
higher rates of depression reported in both retrospective
(27.4%) (67) and prospective (44%) (43) implementa-
tions of the NIMH-dAD compared with other sets of cri-
teria (e.g., DSM-IV, CAMDEX and ICD-10). In support of
Olin et al.’s (46) proposition, Teng et al. (43) demon-
strated that an interview using NIMH-dAD criteria more
effectively distinguishes significant depressive symptoms
in AD patients. Notably, while the symptoms of psy-
chomotor changes, fatigue and guilt/worthlessness were
found to predict depression, the newly included symptoms
of social isolation/withdrawal and irritability were found
not to do so (43). This led the authors to conclude that
these symptoms may be more specific for depressive
manifestation in AD rather than influence the rate of
depression (43). Nonetheless, the NIMH-dAD criteria
have face validity (67), and Rosenberg et al. (72) have
demonstrated their clinical application.
SYMPTOMATIC OVERLAP OR
ASSESSMENT OVERLAP?
Apathy and depression are frequently associated in AD,
due to joint key symptoms of diminished motivation and
interest, vegetative symptoms of psychomotor retardation,
fatigue and hypersomnia, lack of insight and pessimism,
diminished ability to concentrate, and weight loss (9,
11, 60). This symptomatic overlap often results in the mis-
interpretation of apathy as depression, even in the ab-
sence of depressed mood or signs of dysphoria according
to the DSM criteria (5, 11, 60, 68, 71). According to the
DSM-IV criteria for depression, one main symptom is loss
of interest or pleasure in activities, as opposed to de-
pressed mood itself (68). However, in the demented,
this loss of interest or pleasure may reflect a loss of mo-
tivation or ability, rather than a change in affect or de-
pression (5). This both complicates its assessment (44, 47,
60) and results in apathetic individuals meeting the diag-
nostic criteria for major depression, even in the absence
of dysphoric symptoms (5, 11, 70, 71).
The observed overlap may be explained by method-
ological variations of assessments relating to symptoms
common to both syndromes (e.g., closely related subsets
of items, such as diminished interest, psychomotor re-
tardation, lack of energy, loss of insight; or dysphoric
items, such as depressed mood, guilt, hopelessness and
vegetative symptoms) (2, 11, 70, 79). Research has
demonstrated high correlations between apathy and de-
pression scores for items corresponding to symptoms
commonly observed in the syndrome of apathy (2, 12,
26, 80), as well as categorization of patients into cohorts
of “pure apathy”, “pure depression” or “apathy and de-
pression” (3, 10, 45, 81). This has led to the conclusion
that apathy and depression have divergent natural histo-
ries and can be differentiated (7, 82).
Forsell et al. (83, 84) described depressive symptoms
in the elderly as falling into two categories: mood prob-
lems (symptoms of dysphoria, feelings of guilt and suici-
dal ideation) and motivational problems (symptoms of lack
of interest, low energy and psychomotor slowing). De-
pression may be distinguished from apathy (characterized
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differentiate between symptoms of apathy, cognitive im-
pairment and depression, as is the case in Parkinson’s dis-
ease, in which there is an overlap between depression, de-
mentia and apathy (90-92). A third opposing argument is
that both DSM-IV and ICD-10 allow for the diagnosis of
mild or moderate depression in the absence of depressed
mood, while requiring loss of interest or anhedonia (‘in-
ability to experience pleasure, as manifested in facial ex-
pression, speech, behaviour, lifestyle and the individual’s
account of personal experience’), or a decrease in ener-
gy (21, p. 1090, 93). Starkstein and Leentjens (21, p.
1089) rightly question whether: 1) such a definition ad-
equately explains the high co-occurrence of apathy and
depression, 2) such a reliable separation of non-dyspho-
ric depression from apathy may occur, and 3) ‘lack of in-
terest and/or anhedonia are core symptoms of diminished
motivation’, as Starkstein et al.’s (10, 21) apathy diag-
nostic criteria require diminished goal-directed behavior for
apathy (assessed by ‘lack of interest’). Accordingly, the
above argument for apathy as a symptom of depression
must be questioned. On balance, the weight of literary ev-
idence points toward apathy as a separate and distinct syn-
drome from depression, and this view is further sup-
ported by findings on the prevalence of apathy and de-
pression in dementia.
DOES PREVALENCE INDICATE SIMILARITY
OR DIFFERENCE?
Prevalence and progression rates further support ap-
athy as a separate syndrome from depression. Apathy is
a prominent feature of AD-related behavioral and per-
sonality changes (11, 26, 27, 32, 70, 94, 95), appear-
ing early in the course of the disease (reports ranging be-
tween 11 and 39% of individuals with MCI) and in-
creasing in prevalence with illness progression until it is
universal amongst the severely cognitively impaired (up
to 92% of AD patients) (11, 24, 35, 50, 70, 71, 80, 96,
97). Conversely, depression precedes the onset of AD (5,
10, 50, 70, 98, 99) and is often an initial symptom in
AD, appearing in mild to moderate stages (including
MCI) and becoming less prevalent in more severe stages
(46, 56, 100, 101). Prevalence rates of depression (ma-
jor and minor) in AD reportedly range between 30 and
50% (with more extreme studies reporting rates be-
tween 1 and 90%) (44, 46). These inconsistencies may
be explained by the large variability in definition, as-
sessment and clinical manifestation in research (44, 46).
Notably, as AD progresses, the expression of depressive
syndromes changes, resulting in under-recognition of
late-life depression due to clinical and nosological ambi-
guities (83, 102). However, the declining prevalence
of depression in more advanced AD stages may be the
consequence of assessment difficulties, due to advanced
cognitive decline (46, 56).
Apathy also occurs without depression in AD, sug-
by lack of emotional responsiveness) according to dys-
phoric symptoms of sadness, feelings of guilt, self-criticism,
helplessness and hopelessness (11, 85-87). The observed
loss of interest in depression may rather reflect feelings of
despair, pessimism and hopelessness which, combined
with dysphoria in depression, differentiate depression
from apathy (11, 85). Conversely, apathy is distinguish-
able from depression according to lack of emotional re-
sponsiveness, emotional indifference, ‘lack or lessening of
ability to initiate in multiple domains (motor, gait, cogni-
tive)’ and a lack of concern – not all of which are exclu-
sively observed in depressed individuals (11, 13, 71, p.
16, 86, 87).
Differences are also observed for neuropsychiatric
symptoms, apathy being associated with disinhibition and
aberrant motor behavior, and depression with anxiety, ag-
itation, irritability and hallucinations (9, 45). The occurrence
of negative mood and dysphoric symptoms in depres-
sion, but not in apathy, provides a further difference (5).
Various studies have demonstrated differences between ap-
athy and depression in AD for associated cognitive deficits
(11, 30, 88). Research by Kuzis et al. (30) compared
only apathetic, only depressive, and co-morbid apathetic
and depressive early AD patients. In contrast with only de-
pressive patients, only apathetic patients showed specific
cognitive deficits in naming performance, word list learn-
ing, verbal fluency and set-shifting (30). The co-morbid ap-
athetic and depressive group had worse impairments in ab-
stract reasoning ability than those with only apathy, while
no association with cognitive dysfunction was found for the
only depressive group (11, 30).
Although the concept of apathy as a separate syn-
drome from depression has received much valid sup-
port, there are opposing arguments. First, for Marin
(13), the diagnosis of apathy should not be made in the
context of diminished levels of consciousness, moder-
ate or severe cognitive deficits, or marked emotional
distress, as apathy may be an intrinsic symptom of de-
mentia (21). Although this point is useful in identifying a
‘pure’ apathy syndrome ‘uncontaminated by changes in
cognitive or affective domains’, conceptual and empirical
evidence argues against such an approach (21, p. 1089).
One conceptual issue is that a syndrome is defined as a
constellation of symptoms without reference to a specif-
ic etiology, and it is therefore not clear why apathy
should be ‘considered a syndrome in some contexts (e.g.,
stroke) but not in others (e.g., dementia)’ (21, p. 1089).
A second opposing argument is that some psy-
chopathological syndromes (e.g., apathy and depres-
sion) co-occur in some neurodegenerative diseases (21,
26). In response, while the apathetic syndrome is observed
most frequently in ‘individuals with neurological disorders
and some degree of cognitive impairment and depression’
(e.g., AD, stroke, or Parkinson’s disease) (21, p. 1089,
81, 89), this may be due to the inability of assessments to
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gesting that the former is a distinct and distinguishable syn-
drome from depression (3, 11, 21, 45). Marin et al.
(94) demonstrated that 55% of AD patients had high lev-
els of apathy and low levels of depression, whereas 47%
of older adults with major depression had low levels of ap-
athy (11). This suggests differential patterns of apathy and
depression in AD patients and patients with major de-
pression, ‘despite a positive correlation between apathy
and depression scores in both groups’ (11, p. 1704).
These findings of no concomitant depression in AD pa-
tients supports apathy as a separate neuropsychiatric
syndrome from depression.
Other research demonstrates co-occurrence of apathy
and depression varying across neurological conditions, sug-
gesting that these are two neuroanatomically distinct en-
tities (2, 45). Starkstein et al. (26) supported this concept
in their longitudinal examination of the association be-
tween apathy and depression. Their findings that 25% of
non-depressed patients had apathy and that 50% of de-
pressed patients also had apathy led them to conclude that
depression is not a requisite for the presence of apathy in
AD (26). In addition, they found a significant increase in
apathy over time, in that baseline subsyndromal depres-
sion was not associated with follow-up apathy levels and
baseline apathy levels were a significant predictor of in-
creased follow-up depression (26). This last finding led
them to suggest that apathy may be either an early indi-
cator for depression or a prodromal stage of depression
(26). However, in the latter case, the prevalence rates of
apathy should reflect higher levels of apathy prior to de-
pression. This is not found. While depression is most com-
mon in early stages and decreases in prevalence with cog-
nitive decline, apathy increases with increasing cognitive
impairment. Therefore, although apathy may be a possible
risk factor for the development of later life depression,
Starkstein et al.’s (26) proposal of apathy as a prodromal
stage of depression requires further investigation. Ac-
cordingly, on the basis of current understanding of the
prevalence and progression rates of apathy and depres-
sion, it is plausible to postulate that apathy and depression
are separate syndromes in dementia.
In summary, apathy and depression differ according to
prevalence and progression rates. While apathy occurs in
early and mild stages of cognitive impairment and in-
creases in prevalence to become universal among the
severely cognitively impaired, depression is an initial
symptom, already apparent in the pre-clinical stage of MCI
and mild to moderate stages of impairment. In contrast to
apathy, depression becomes less prevalent with increas-
ing cognitive decline, perhaps as a consequence of
methodological limitations (e.g., AD pathology, cognitive
decline, and unwillingness or inability to disclose the oc-
currence of such neuropsychiatric symptoms). The de-
velopment of more accurate and effective ways of as-
sessing such neuropsychiatric symptoms is required when
diagnosis is not predominantly dependent on caregiver re-
ports or clinical interpretations.
A NEUROPATHOLOGICAL EXPLANATION?
Similarities and differences in apathy and depression
have not only been found in symptomatic overlaps, but al-
so on a neuropathological level (11). Apathy is most
commonly observed in combination with damage to the
frontal lobes or subcortical structures connecting them
(e.g., frontal lobe lesion) and impairments in these areas
are associated particularly with executive dysfunction
and cognitive and behavioral changes (11, 38, 71, 103,
104). In particular, apathy is ‘correlated with neuronal loss,
higher tangle counts and white-matter hyperintensities in
areas that are thought to be essential components’ of
frontal subcortical circuits (11, p. 1701, 105-110). No-
tably, patients with moderate or severe apathy demon-
strate significantly reduced blood flow in the anterior
temporal, orbito-frontal, anterior cingulate and dorso-
lateral prefrontal regions, compared with those with no or
mild apathy (31, 50, 111, 112). These findings have re-
sulted in the implication that ‘apathy is associated with
specific cognitive impairment caused by disruption of
these brain areas’ (29, p. 2) and, specifically, the in-
volvement of frontal-subcortical circuits originating from
frontal cortical regions, which mediate executive function
and motivation in apathetic patients (30, 31, 113, 114).
Thus, apathy in AD has been closely associated with
neuropathological impairments in components of the
anterior cingulate frontal-subcortical circuit (e.g., anterior
cingulate, nucleus basalis of Meynert, hippocampus, me-
dial frontal region) (5, 105-108).
Conversely, the neuropathology of depression in AD
is primarily associated with frontal-striatal and subcortical
limbic structures (locus ceruleus, substantia nigra, hip-
pocampus and hypothalamus) (5, 9, 50, 115, 116).
Post-mortem evidence has demonstrated a reduction in
the locus ceruleus cell population, the number of sub-
stantia nigra cells, and neurochemical changes, i.e.,
marked reduction of norepinephrine levels in the middle
frontal and temporal cortex cortical regions, increased en-
torhinal cortex dopamine levels, and normal frontal and
temporal cortex serotonin levels – even with significant re-
duction of serotonin uptake sites in the temporal re-
gions (117-121). Post-mortem evidence also suggests se-
lective noradrenergic cell loss in the locus ceruleus and loss
of dorsal raphe serotonergic nuclei (56, 119, 122-125).
Apoptotic processes occurring as a function of AD may
also contribute to the loss of aminergic nuclei, in turn af-
fecting mood (46, 126). Interestingly, the presence of de-
pression correlates with elevated global scores of deep
white matter lesions, particularly to frontal lobe white mat-
ter (127, 128). However, although findings of functional
neuroimaging studies are inconsistent, AD-related de-
pression has been associated with reduced parietal lobe
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metabolism, cerebral hypoprofusion in temporal-pari-
etal regions, and hemispheric hypoperfusion in the dor-
solateral, frontal, temporal and parietal regions (50).
In summary, while apathy in AD is associated with ab-
normalities of frontal subcortical circuits (specifically, the
‘anterior cingulated which is thought to be responsible for
motivated behavior’) (29, p. 2), AD-related depression is
associated with neuropathology of frontal-striatal and
subcortical limbic circuits (e.g., locus ceruleus, substantia
nigra, hippocampus, hypothalamus) (9).
Apathy and depression are neuropathologically similar,
due to hypoperfusion or hypoactivity in frontal, parietal
and temporal regions (5, 9, 11, 108, 111, 115, 116,
129-132). Landes et al. (11, p. 1704) suggested that the
‘co-occurrence of apathy and depression may relate to in-
volvement of frontal subcortical circuits in both syn-
dromes’. Other research proposes mixed behavioral pre-
sentation of apathy and depression, due to impairment of
the frontal circuitry in major depression resulting from the
proximity of such subcortical circuits (i.e., a subcortical le-
sion simultaneously affects multiple circuits) (11, 39, 45,
104, 133, 134). However, while the involvement of
frontal subcortical circuits has a long-standing tradition as
a heuristic explanation of behavioral problems in neu-
ropsychiatry, this hypothesis may lack heuristic value, as
neuropathological differences have been observed in
which ‘AD patients with isolated motivational or mood dis-
turbances reveal differing cortical dysfunction during ear-
ly disease, confirming a different neuroanatomical basis for
the emergence of apathy and depression in AD’ (135, p.
418). Holthoff et al.’s (135) positron emission tomography
study showed that apathetic early AD patients had signif-
icant glucose metabolism decreases in the left orbitofrontal
regions, while hypometabolism in the dorsolateral pre-
frontal regions was associated with depression.
Other research suggests that apathy and depression dif-
fer on a neurochemical basis, apathy being associated with
cholinergic deficits and depression with serotoninergic
deficits or a dopamine and norepinepherine imbalance (5,
50, 136-138). Symptoms of apathy in early AD are re-
lated to cholinergic input loss to the prefrontal and sub-
cortical structures of the nucleus basalis of Meynert,
whereas deepening apathy in later stages results from se-
vere cholinergic denervation, and involvement of the
prefrontal cortex and the anterior and medial temporal
structures supplying adherent input to this circuit (9, 11).
Thus, an interaction between neuropathological frontal
brain changes and cholinergic deficiency is reflected in AD-
related apathy (9).
The identification of more pronounced apathetic
symptoms in AD patients exhibiting extra-pyramidal
symptoms and empirical results on modulated dopamin-
ergic neurotransmission treatment further suggest that
dopamine plays a mediating role in apathetic AD patients
(11, 71, 139). Conversely, serotoninergic agents (e.g., se-
lective serotonin re-uptake inhibitors) may worsen apa-
thetic symptoms but relieve depression (45, 86, 140-
143). While apathy treatment may be supported by in-
creasing dopaminergic function, serotonergic activity
increase is detrimental (33). Thus, cholinomimetic agents
reduce apathy but do not affect mood, so that only ap-
athy, and not depression, is relieved by dopaminergic
agents (45, 144). One explanation is that depression re-
sults from an imbalance in paralimbic neurotransmitter
function, whereas apathy may be traced to a functional
disconnection of the cortex from the relevant paralimbic
input (9). While the treatment of apathy with
cholinesterase inhibitors (e.g., tacrine) has demonstrated
significant reductions in apathetic symptoms in AD,
suggesting a ‘cholinergic contribution to the patho-
physiology of apathy in AD’ (50, p. 852, 145), be-
tween 38% (146) and 60% of patients (147) do not re-
spond to this treatment (33). This involvement of differing
neurochemical pathways and, to some extent, of neu-
ropathological structures may therefore be a further in-
dication that apathy and depression are two separate syn-
dromes in dementia.
In summary, apathy in AD is associated with bilateral
hypoperfusion within the basal ganglia and dorsolateral
prefrontal cortex (132), reduction in perfusion of anteri-
or temporal, orbito-frontal, anterior cingulate and dor-
solateral prefrontal regions (148, 149), hypometabolism
in left orbitofrontal areas (135), and left anterior cingulate
neurofibrillary tangle burden (105). Conversely, AD-related
depression is associated with hypometabolism in the left
prefrontal cortex and superior frontal cortex (135), white
matter lesions (127), reduced glucose metabolism in the
bilateral anterior cingulate and superior temporal cor-
tex (132) and bilateral superior frontal and left anterior cin-
gulate cortex (131) or parietal lobes (150).
CONCLUSIONS AND FUTURE DIRECTIONS
Although no consensus on the nosological position of
apathy in dementia has been reached, apathy, despite
some symptomatic overlap with depression, may be
viewed as a separate syndrome from depression in de-
mentia. This review provides an overview of the literature
focusing on the areas of clinical manifestation, sympto-
mology, assessment, prevalence, and neuropathology. We
conclude that, given the evidence, the arguments in sup-
port of apathy as a separate syndrome from depression in
dementia are persuasive. However, the fact that the def-
initions of apathy and depression overlap in terms of
key symptoms, resulting in a high mis-diagnosis of apathy
as depression, raises some concerns. These concerns
regard treatment, as medical treatment of depression
does not alleviate the negative impact of apathy. To
provide sufficient support to individuals suffering from de-
mentia and their caregivers, it is vital that apathy as a syn-
drome should be recognized and treated. Reaching a
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consensus on the definition of apathy within dementia is
essential if patients suffering from such neuropsychiatric
symptoms are to receive deserved support and atten-
tion.
A consensus on the definition of apathy and its noso-
logical position will lead to better development and im-
plementation of diagnostic measures and criteria, more
effective research and clinical practice, and better un-
derstanding of associated neuropsychiatric disorders in de-
mentia. The identification of apathy as a separate syn-
drome and its management (whether pharmacologically
or non-pharmacologically) requires better understanding
of potential risk factors for both apathy and depression
in dementia. This is important when considering the
direction of future research, specifically on potentially
modifiable risk factors for the development of apathy and
depression in dementia. While there is ample research on
risk factors of AD (151), little research has focused on risk
factors for apathy and depression in dementia. Future re-
search should consider the role of behavioral and cog-
nitive models in this context, as these may not only
provide further insight and understanding of the multi-di-
mensionality involved in neuropsychiatric symptoms in
dementia, in which depression and/or apathy may not
only be characterized as a deficit in motivation or mood,
but may also reflect transient modalities to adapt to
their environment (152). Future research should also
consider the possibility of conversion between apathy and
depression, and vice versa, as this may provide further
understanding of risk factors. Mortby et al. (153) were the
first to study midlife motivational abilities as predictors of
apathy and depression in dementia, demonstrating that
midlife motivational abilities moderate the causal rela-
tionship between cognitive impairment and apathy, but
not depression. The findings by Mortby et al. (153) – that
depression remained stable over time, regardless of
severity of impairment, but that apathy increased over
time in AD patients – may be interpreted as additional
support to the view that apathy and depression are two
separate syndromes (11). These findings may provide a
new perspective to the ongoing debate on whether be-
havioral and psychological symptoms of dementia reflect
pre-morbid personality traits (e.g., 154-156) preceding
apathy and/or depression in dementia. Specifically,
these findings may provide stimulation for future re-
search into personality factors or coping styles, to de-
termine whether apathy and/or depression are a state or
trait in dementia, as this may provide additional insight in-
to the best approaches for prevention and treatment of
both.
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